Mantovani, L.G. et al. 2017. [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]. Farmeconomia. Health economics and therapeutic pathways. 18, 2S (Dec. 2017). DOI:https://doi.org/10.7175/fe.v18i2s.1320.